Sickle Cell Disease and Hematopoietic Cell Transplantation

Item #: 720 Type: PDF

This clinical resource explores HCT as a therapy for patients with sickle cell disease (SCD), by examining the following topics:

  • Risk/benefit analysis for treatment decision-making
  • Clinical trials, including Medicare coverage for HCT
  • Research addressing quality of life issues
  • HCT outcomes
  • Trends in access to transplant for patients with SCD 

  • Sickle Cell Disease and Hematopoietic Cell Transplantation